Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bridging Safety & Immunogenicity of RTS,S/AS01E vs RTS,S/AS02D in Gabonese Children
NCT00307021Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2006
- Primary completion
- Sep 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of RTS,S in malaria and hepatitis B (HBV) (2 arms), sponsored by GSK. Primary endpoints: Occurrence of Serious Adverse Events and Antibody titers to the P. falciparum circumsporozoite repeat domain. Started Apr 2006; status: completed.
02
Drugs
RTS,S
03
Conditions
malariahepatitis B (HBV)
Beyond the preview
Go deeper on NCT00307021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00307021.